CPT® Code 81186

The CPT® Code 81186 pertains to the molecular genetic testing of the CACNA1A gene, specifically focusing on the analysis of known familial variants associated with spinocerebellar ataxia type 6 (SCA6). This genetic condition is characterized by a gradual degeneration of the cerebellum and spinal cord, leading to a range of neurological symptoms. The CACNA1A gene, located on the short arm of chromosome 19 at position 13.13 (19p13.13), encodes a subunit of calcium voltage-gated channels, which are essential for the transport of calcium ions across cell membranes. These channels play a critical role in neuronal communication and neurotransmitter release. The gene contains a specific region that features a trinucleotide repeat sequence of CAG (cytosine-adenine-guanine), which typically repeats between 4 to 18 times in healthy individuals. However, in individuals with SCA6, this repeat can expand to between 20 to 33 times, with the number of repeats correlating with the age of onset and severity of symptoms. Symptoms of SCA6 may include uncoordinated gait (ataxia), dystonia, tremors, loss of coordination in the arms, speech difficulties (dysarthria), involuntary eye movements (nystagmus), and double vision. The analysis performed under CPT® Code 81186 is crucial for identifying these known familial variants, which can help in assessing the risk for family members who may inherit the condition. This testing is part of a broader genetic evaluation process that may also include other codes such as 81184, which detects abnormal alleles, and 81185, which involves a full sequence analysis to identify functional variants. Overall, the use of CPT® Code 81186 is essential for understanding the genetic underpinnings of SCA6 and for guiding clinical management and family planning for affected individuals.